Observation of rituximab as initial treatment in patients with minimal change disease- a retrospective study
Research backgroundThis study was aimed to retrospectively investigate the efficacy and safety of rituximab (RTX) versus glucocorticoids (GC) as initial treatments for patients with minimal change disease (MCD).Research methodsPatients who were diagnosed with MCD through kidney biopsy and received R...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1528996/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|